ClinConnect ClinConnect Logo
Search / Trial NCT06396000

Factors Analysis Related to Prolonged Stay in the Pediatric Post-Anesthesia Care Unit(PACU)

Launched by SAIQIANG GUO · Apr 29, 2024

Trial Information

Current as of July 22, 2025

Not yet recruiting

Keywords

Post Anesthesia Care Unit Risk Factors Pediatrics

ClinConnect Summary

This clinical trial is looking into why some children stay longer than others in the Pediatric Post-Anesthesia Care Unit (PACU) after surgery. The PACU is where kids go right after anesthesia, and sometimes, they need more time there for various reasons. By understanding these factors, the study hopes to improve care and help children recover more efficiently.

To be part of this study, children aged 0 to 18 years who are having emergency surgery or have certain medical conditions may be eligible. This includes kids with incomplete medical histories or those who have serious health issues affecting their brain, liver, kidneys, lungs, or heart. If your child qualifies and decides to participate, they can expect to be monitored closely after surgery to help researchers gather important information. It’s important to note that this trial is not yet recruiting participants, so there will be more information available in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Children aged 0-18 years old; Child entering the Pediatric Post-Anesthesia Care.
  • Emergency surgery; Pediatric patients with incomplete medical history; Pediatric patients requiring postoperative ICU care; Pediatric patients with preoperative altered consciousness; Neurological disorders; Severe liver, kidney, lung, and heart diseases.

About Saiqiang Guo

Saiqiang Guo is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative trial designs and rigorous methodologies. With a focus on enhancing therapeutic options across various diseases, the organization emphasizes collaboration with healthcare professionals, regulatory bodies, and research institutions. Saiqiang Guo leverages cutting-edge technology and comprehensive data analysis to ensure the highest standards of safety, efficacy, and ethical conduct in all clinical studies. Their mission is to contribute to the scientific community by generating robust evidence that supports the development of new treatments and enhances patient care globally.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported